Antares Pharma Inc (NASDAQ:ATRS)

2.27
Delayed Data
As of Apr 24
 -0.03 / -1.30%
Today’s Change
1.58
Today|||52-Week Range
4.09
+14.07%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-35.2M-20.7M-24.3M-16.7M
 
 
 
 
 
Depreciation1.2M1.6M1.9M2.1M
 
 
 
 
 
Total Other Cash Flow6.2M4.5M3.5M3.2M
 
 
 
 
 
Funds From Operations-27.7M-14.6M-18.9M-11.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.4M13.7M-3.7M11.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-26.3M-28.3M-15.2M-23.1M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-15.0M0.00-10.0M
 
 
 
Decrease In Investments24.0M6.0M15.0M5.0M
 
 
 
 
 
Capital Expenditures-4.7M-5.6M-4.9M-1.2M
 
 
 
 
 
Fixed Asset Disposal------1.9M
 
 
Net Cash Flow Investing18.3M-15.7M10.0M-4.3M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.0024.7M
 
 
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale3.1M42.9M101.1K1.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing--0.00------
Other Uses - Financing154.4K0.0083.6K249.0K
 
 
 
 
Net Cash Flow - Financing3.0M42.9M17.5K26.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-2.6K-733.0058.00-1.0K
 
 
 
 
 
 
Net Change In Cash-5.0M-1.1M-5.2M-1.2M